A detailed history of Vr Adviser, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 2,173,913 shares of DYN stock, worth $52 Million. This represents 8.09% of its overall portfolio holdings.

Number of Shares
2,173,913
Previous 2,173,913 -0.0%
Holding current value
$52 Million
Previous $76.7 Million 1.78%
% of portfolio
8.09%
Previous 8.42%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$8.53 - $14.28 $18.5 Million - $31 Million
2,173,913 New
2,173,913 $24.5 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Vr Adviser, LLC Portfolio

Follow Vr Adviser, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.